Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Novo Nordisk shares jump close to 14% on promising trial results for amycretin, a once-weekly obesity drug, signaling fierce ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

Investing in stocks with high valuations isn't necessarily a bad decision, but it's something to be done deliberately and ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Colorado plans to start limiting insurance coverage of prescription weight-loss drugs for its roughly 40,000 state employees, a cost-cutting measure in a difficult budget year that officials say will ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

Security Information and Event Management (SIEM) systems are now a critical component of enterprise security. Learn more from Smarttech247 about how its VisionX + Splunk solution can help secure ...

Trump Officials Move to Quickly Expel Migrants Biden Allowed In Temporarily A memo appears to allow Immigration and Customs Enforcement officials to target Biden-era programs that let in more than ...